ClinConnect ClinConnect Logo
Search / Trial NCT05992415

New York City Eye Study (NYCES)

Launched by COLUMBIA UNIVERSITY · Aug 7, 2023

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

The New York City Eye Study (NYCES) is a research project aimed at improving eye and vision health for adults aged 21 and older. The study will conduct eye health screenings to check for conditions such as glaucoma, cataracts, diabetic retinopathy, and other vision impairments. This is important as these conditions can lead to serious vision problems, including blindness. While the study is not yet recruiting participants, it will focus on individuals who live independently in affordable housing developments and their neighborhoods.

To be eligible for the study, you need to be at least 21 years old and live in the specified areas. However, if you have a serious illness with a life expectancy of less than a year, or if you have difficulty understanding or providing consent due to conditions like dementia, you won’t be able to participate. If you join the study, you can expect to undergo eye screenings that will help researchers better understand and address vision health in the community. This research is a valuable opportunity to contribute to the understanding of eye health and potentially improve care for many people.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals age 21 and older.
  • Living independently in an affordable housing development and surrounding neighborhoods.
  • Exclusion Criteria:
  • Self-reported terminal illness with life expectancy less than 1 year.
  • Inability to provide informed consent due to dementia or other reasons.

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Lisa A. Hark

Principal Investigator

Columbia University Department of Ophthalmology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported